Survivors of childhood central nervous system cancer show affected self-identity
the ONA take:
According to a new study published in the journal Neuro-Oncology, researchers from the Korlinska Institutet in Sweden have found that patients treated for central nervous system (CNS) cancer during childhood or adolescence can display altered self-perception and self-identify later in adulthood.
For the study, researchers followed 700 adult survivors of childhood CNS cancer who were diagnosed between 1992 and 2001. Researchers compared these patients to a control group from the general population. They studied how the cancer, the treatment, and the aftermath affected the patient's health, function, and psychological identity. Psychological identity includes their self-perception and self-esteem, which researchers assessed using a standardized self-report questionnaire.
Results showed that all components of having CNS cancer affected patients' psychological identity later in adulthood. Researchers found survivors more often had a negative self-perception compared with the control group.
For example, in the context of work and friends, 22% and 30% of survivors had a negative self-perception, respectively, while 8% and 17% of the control group had a negative self-perception, respectively.
Results of self-perception were similar across both groups in the context of family. Findings suggest that more preventative measures are necessary to aid in long-term personality development.
Patients treated for CNS cancer during childhood can display altered self-perception later in adulthood.
The study followed 700 adult survivors diagnosed 1992-2001 with a childhood CNS tumour. The study group covered all adult brain tumour survivors in Sweden at the time of start of study. Patients were compared with a control group selected from the general population.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Patients and Caregivers Worry About Cost of Cancer Care
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|